Therefore, we explored the long-term consequences of FLCN loss through transcriptomic and proteomic analysis to better characterize FLCN as a tumor suppressor, and in doing so uncovered links to DNA-PK and cell cycle control. The gene discussed is FLCN; the disease is neoplasm.